Key Highlights
- Atropos Health adds Forian and Syndesis Health to Evidence Network.
- New customer TD2 gains access to enhanced clinical insights.
- Expansion supports personalized and precise medicine.
- GENEVA OS™ facilitates secure, rapid clinical data access.
- Real World Fitness Score™ ensures data quality and relevance.
Source: Business Wire
Notable Quotes
- “We are excited to welcome these new partners to the Atropos Evidence Network. As the largest federated healthcare data network, our commitment to members is to reduce data security and identity management risks, bring them great tools to add automation, efficiency, and transparency to their own processes, and allow them to create value for the significant investments they have made in data quality and data enrichment.” — Dr. Brigham Hyde, CEO and co-Founder at Atropos Health
- “Our partnership with Atropos Health underscores our commitment to advancing precision medicine by leveraging Syndesis Health’s extensive datasets. With data spanning 15 countries outside of the US and approximately 35 million patients, we are uniquely positioned to ensure that the advancements in precision medicine reflect both geographic and ethnic diversity.” — Josh Sutton, CEO at Syndesis Health
- “This collaboration will enable us to leverage high-quality real-world data to optimize clinical trial designs and improve patient outcomes. By integrating Atropos Health’s innovative tools and extensive data sets, we can accelerate the development of new oncology therapies and bring them to patients with greater precision and speed.” — Stephen Gately, PhD, President and CEO at TD2
SoHC's Take
The expansion of the Atropos Evidence Network marks a significant milestone in the integration of real-world data for advancing personalized medicine. By incorporating high-quality datasets from new partners like Forian and Syndesis Health, Atropos Health enhances its ability to provide precise, evidence-based insights to healthcare and life sciences organizations. The inclusion of TD2 as a customer highlights the growing demand for robust clinical data to optimize patient outcomes and streamline clinical trials. The use of GENEVA OS™ and the Real World Fitness Score™ ensures that data quality and security are maintained, fostering trust and efficacy in clinical decision-making. This strategic expansion not only broadens the network’s capabilities but also strengthens the foundation for future innovations in healthcare analytics.
